Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 13;11(3):302.
doi: 10.3390/genes11030302.

Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia

Affiliations

Transcriptome Analysis Identifies LINC00152 as a Biomarker of Early Relapse and Mortality in Acute Lymphoblastic Leukemia

Diego Alberto Bárcenas-López et al. Genes (Basel). .

Abstract

Evidence showing the role of long non-coding RNAs (lncRNAs) in leukemogenesis have emerged in the last decade. It has been proposed that these genes can be used as diagnosis and/or prognosis biomarkers in childhood acute lymphoblastic leukemia (ALL). To know if lncRNAs are associated with early relapse and early mortality, a microarray-based gene expression analysis in children with B-lineage ALL (B-ALL) was conducted. Cox regression analyses were performed. Hazard ratios (HR) and 95% confidence intervals (95% CI) were calculated. LINC00152 and LINC01013 were among the most differentially expressed genes in patients with early relapse and early mortality. For LINC00152 high expression, the risks of relapse and death were HR: 4.16 (95% CI: 1.46-11.86) and HR: 1.99 (95% CI: 0.66-6.02), respectively; for LINC01013 low expression, the risks of relapse and death were HR: 3.03 (95% CI: 1.14-8.05) and HR: 6.87 (95% CI: 1.50-31.48), respectively. These results were adjusted by NCI risk criteria and chemotherapy regimen. The lncRNA-mRNA co-expression analysis showed that LINC00152 potentially regulates genes involved in cell substrate adhesion and peptidyl-tyrosine autophosphorylation biological processes. The results of the present study point out that LINC00152 could be a potential biomarker of relapse in children with B-ALL.

Keywords: LINC001013; LINC00152; acute lymphoblastic leukemia; early relapse; long noncoding RNA; microarray expression analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Differentially expressed genes in pediatric patients with acute lymphoblastic leukemia with early relapse vs. non-relapsed cases. Rows display the genes identified, while the columns represent samples (early relapse: pink color and no-relapse: blue). Genes significantly down-regulated are displayed in green and up-regulated genes in red.
Figure 2
Figure 2
LncRNA–mRNA co-expression. Showing a positive (blue) or negative (brown) correlation between differentially expressed lncRNA and mRNA.
Figure 3
Figure 3
Kaplan–Meier plots (unadjusted) of overall survival for patients with pre-B acute lymphoblastic leukemia. Normalized array expression was used to determine either high (above median) or low (below median) expression of both lncRNAs (p-value was calculated with two-sided log-rank test).
Figure 4
Figure 4
Survival analysis between a low/high expression of LINC00152 with relapse.

References

    1. Barrington-Trimis J.L., Cockburn M., Metayer C., Gauderman W.J., Wiemels J., McKean-Cowdin R. Trends in childhood leukemia incidence over two decades from 1992 to 2013. Int. J. Cancer. 2017;140:1000–1008. doi: 10.1002/ijc.30487. - DOI - PMC - PubMed
    1. Rivera-Luna R., Velasco-Hidalgo L., Zapata-Tarrés M., Cárdenas-Cardos R., Aguilar-Ortiz M.R. Current outlook of childhood cancer epidemiology in a middle-income country under a public health insurance program. Pediatr. Hematol. Oncol. 2017;34:43–50. doi: 10.1080/08880018.2016.1276236. - DOI - PubMed
    1. Linet M.S., Brown L.M., Mbulaiteye S.M., Check D., Ostroumova E., Landgren A., Devesa S.S. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years. Int. J. Cancer. 2016;138:1862–1874. doi: 10.1002/ijc.29924. - DOI - PMC - PubMed
    1. Jiménez-Hernández E., Jaimes-Reyes E.Z., Arellano-Galindo J., García-Jiménez X., Tiznado-García H.M., Dueñas-González M.T., Martínez-Villegas O., Sánchez-Jara B., Bekker-Méndez V.C., Ortíz-Torres M.G., et al. Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00–01. Biomed. Res. Int. 2015;2015:1–9. doi: 10.1155/2015/576950. - DOI - PMC - PubMed
    1. Martín-Trejo J.A., Núñez-Enríquez J.C., Fajardo-Gutiérrez A., Medina-Sansón A., Flores-Lujano J., Jiménez-Hernández E., Amador-Sanchez R., Peñaloza-González J.G., Álvarez-Rodríguez F.J., Bolea-Murga V., et al. Early mortality in children with acute lymphoblastic leukemia in a developing country: The role of malnutrition at diagnosis. A multicenter cohort MIGICCL study. Leuk. Lymphoma. 2017;58:898–908. doi: 10.1080/10428194.2016.1219904. - DOI - PubMed

Publication types

Substances

LinkOut - more resources